Can the Mini-Mental State Examination Predict Capacity to Consent to Treatment?
Abstract
This study examines the relationship between capacity to consent to treatment as measured by the MacArthur Competence Assessment Tool for Treatment (MacCAT-T) and severity of cognitive impairment as measured with the Mini-Mental State Examination (MMSE). It also looks at the role of verbal retrieval in this relationship. We hypothesized that the often-quoted correlation between the MacCAT-T and the MMSE lies mainly in the joint dependence on verbal retrieval ability. Potential subjects were recruited from memory clinics, senior citizen meeting places, and a university program for seniors. Data of 149 people over 54 years, 49 of whom had been diagnosed with Alzheimer’s disease or mixed dementia, were used. The relationship between capacity to consent to treatment, verbal retrieval, and MMSE was examined using a structural equation modeling framework. The findings suggest that verbal retrieval is a confounding method factor. In the informed consent process for people with dementia, verbal memory loads should be minimized to provide a more valid measure of their capacity to consent to treatment.
References
2008). Assessment of older adults with diminished capacity: A handbook for psychologists. Retrieved from www.apa.org/pi/aging/programs/assessment/capacity-psychologist-handbook.pdf
. (2007). Assessment of patients’ competence to consent to treatment. The New England Journal of Medicine, 357, 1834–1840. doi 10.1056/NEJMcp074045
(2003). Effects of working memory deficits on the communicative functioning of Alzheimer’s dementia patients. Journal of Communication Disorders, 36, 209–219. doi 10.1016/S0021-9924(03)00020-0
(2014). General comment on Article 12: Equal recognition before the law. Retrieved from www.ohchr.org/EN/HRBodies/CRPD/Pages/DGCArticles12And9.aspx
(2001). Enhancing informed consent for research and treatment. Neuropsychopharmacology, 24, 595–607. doi 10.1016/S0893-133X(00)00218-9
(1999). Factor structure of capacity to consent to medical treatment in patients with Alzheimer’s disease: An exploratory study. Journal of Forensic Neuropsychology, 1, 27–48. doi 10.1300/J151v01n01_03
(1993). Hopemont Capacity Assessment Inventory. Unpublished manuscript, Department of Psychology, West Virginia University, Morgantown, VA.
(1999). Assessment of patient capacity to consent to treatment. Journal of General Internal Medicine, 14, 27–34. doi 10.1046/j.1525-1497.1999.00277.x
(2013). Einwilligungsfähigkeit bei Demenz: Sensitivität des MMST in einer hypothetischen Einwilligungssituation und spezifische kognitive Korrelate [
(Consent capacity in dementia: Sensitivity of MMSE in a hypothetical consent situation and specific cognitive correlates ]. Zeitschrift für Neuropsychologie, 24, 267–275. doi 10.1024/1016-264X/a0001061975). Mini-Mental State: A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 12, 189–198.
(1991). Mentally ill and nonmentally ill patients’ ability to understand informed consent disclosures for medication: Preliminary data. Law and Human Behavior, 15, 377–388.
(1998). MacArthur Competence Assessment Tool for Treatment (MacCAT- T). Sarasota, FL: Professional Resource Press.
(1997). The MacCAT-T: A clinical tool to assess patients’ capacities to make treatment decisions. Psychiatric Services, 48, 1415–1419.
(2006). Cognitive performance predicts treatment decisional abilities in mild to moderate dementia. Neurology, 66, 1367–1372. doi 10.1212/01.wnl.0000210527.13661.d1
(2009). Information for all. European standards for making information easy to read and understand. Retrieved from inclusion-europe.org/images/stories/documents/Project_Pathways1/Information_for_all.pdf
(1978). The Boston Naming Test. Boston, MA: Veterans Administration Medical Center.
(2005). The ability of persons with Alzheimer disease (AD) to make a decision about taking an AD treatment. Neurology, 64, 1514–1519. doi 10.1212/01.WNL.0000160000.01742.9D
(1999). Experimentally disentangling what’s beneficial about elderspeak from what’s not. Psychology and Aging, 14, 656–670. doi 10.1037/0882-7974.14.4.656
(1996). Toward a neurologic model of competency: Cognitive predictors of capacity to consent in Alzheimer’s disease using three different legal standards. Neurology, 46, 666–672. doi 10.1212/WNL.46.3.666
(1997). Consistency of physician judgments of capacity to consent in mild Alzheimer’s disease. Journal of the American Geriatrics Society, 45, 453–457.
(2007). Assessment of decision-making capacity in older adults: An emerging area of practice and research. Journals of Gerontology Series B: Psychological Sciences and Social Sciences, 62, 3–11.
(2004). Capacity to consent to treatment: Empirical comparison of three instruments in older adults with and without dementia. The Gerontologist, 44, 166–175. doi 10.1093/geront/44.2.166
(2006). Neuropsychological predictors of decision-making capacity over 9 months in mild-to-moderate dementia. The Journal of General Internal Medicine, 21, 78–83. doi 10.1111/j.1525-1497. 2005.00288.x
(2002). Latent variable analysis with categorical outcomes: Multiple-group and growth modeling in Mplus. Mplus Web Notes: No. 4, Version 5.
(1998–2011). Mplus user’s guide (6th ed.). Los Angeles, CA: Muthén & Muthén.
(2006). Convention on the rights of persons with disabilities. Retrieved from www.ohchr.org/EN/HRBodies/CRPD/Pages/ConventionRightsPersonsWithDisabilities.aspx
(1995). Competence of long-term care residents to participate in decisions about their medical care: a brief objective assessment. The Gerontologist, 35, 622–629. doi 10.1093/geront/35.5.622
(1998). Discrimination of facial identity and of emotions in Alzheimer’s disease. Journal of the Neurological Sciences, 154, 151–158. doi 10.1016/S0022-510X(97)00222-0
(2005). Die Verhandlungsfähigkeit des alten (multimorbiden) Patienten [
(Competency of the (multimorbid) aged patient ]. Rechtsmedizin, 15, 143–147. doi 10.1007/s00194-005-0318-22008). Patientenselbstbestimmung und Selbstbestimmungsfähigkeit: Beiträge zur klinischen Ethik [
(Patient autonomy and capacity to consent: Contributions to medical ethics ]. Stuttgart: Kohlhammer.1997). Wechsler Adult Intelligence Scale-III Manual. New York: Psychological Corporation.
(1997). Neuropsychological assessment of Alzheimer’s disease. Neurology, 49 (Suppl 3), S11–S13. doi 10.1212/WNL.49.3_Suppl_3.S11
(1994). The consortium to establish a registry for Alzheimer’s disease (CERAD). Part V: A normative study of the neuropsychological battery. Neurology, 44, 609–614. doi 10.1212/WNL.44.4.609
(1983). Development and validation of a geriatric depression screening scale: A preliminary report. Journal of Psychiatric Research, 17, 37–49. doi 10.1016/0022-3956(82) 90033-4
(